Search icon
Learn, Analyse & Invest
only with
Orca logoArrow icon
+91
Download Orca
orca play storeorca apple store
To access realtime data for Reliance Industries Ltd, and use advance features for tradingRegisterorLogin to Orca.

SMS Pharmaceuticals Ltd.

SMS Pharmaceuticals

0.00

0.00 (0.00)%

NSE

BSE

EX-DatePurpose
28 05 2021 Audited Results
07 08 2021 Quarterly Results
12 11 2021 Quarterly Results
09 02 2022 Quarterly Results
30 05 2022 Final Dividend & Audited Results
13 08 2022 Quarterly Results
12 11 2022 Quarterly Results
09 02 2023 Quarterly Results
24 05 2023 Final Dividend & Audited Results
08 08 2023 Quarterly Results
08 11 2023 Quarterly Results
08 02 2024 Quarterly Results & Preferential Issue of shares & Inter-alia shall also consider the proposal for fund raising by way of issue of equity shares/ warrants and/or any other instruments/ securities on preferential basis
08 11 2024 Quarterly Results
12 02 2025 Quarterly Results
30 05 2025 Final Dividend & Audited Results
09 08 2025 Quarterly Results
09 08 2025 Quarterly Results
08 11 2025 Quarterly Results
07 02 2026 Quarterly Results

News

13-DEC-2025

USFDA completes inspection at SMS Pharmaceuticals’ API manufacturing facility at Visakhapatnam

The inspection concluded with one minor observation in Form 483

12:29 PM
26-NOV-2025

SMS Pharmaceuticals’ associate gets USFDA nod for reformulated Ranitidine tablets

The approval by the US FDA comes after extensive safety testing and manufacturing improvements that address previous concerns regarding the formation of NDMA impurity

10:47 AM
28-AUG-2025

SMS Pharmaceuticals gets EIR for Central Laboratory Analytical Services

The company has received the EIR with ‘No Action Indicated’ status

12:50 PM
25-JUN-2025

USFDA concludes inspection at SMS Pharmaceuticals’ Central Laboratory Analytical Services

The inspection, conducted from June 23, 2025 to June 25, 2025, concluded with zero Form 483 observations

06:36 PM
22-MAR-2025

SMS Pharmaceuticals completes USFDA inspection at Hyderabad facility

The inspection, conducted from March 17, 2025 to March 21, 2025, concluded with one observation in Form 483

11:54 AM
19-OCT-2022

SMS Pharmaceuticals acquires 4.9% stake in Provenio Astral International LLP

This strategic partnership may help the company to expand its business in overseas and also If the company wish to establish any facility in overseas in future

12:27 PM
22-JUL-2022

SMS Pharmaceuticals gets CEP approval for Ibuprofen

The company will continue to explore avenues to further grow the revenue from Ibuprofen

06:03 PM
Enrich money logo